UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Exceptional Response to Pembrolizumab in a Metastatic, Chemotherapy/Radiation-Resistant Ovarian Cancer Patient Harboring a PD-L1-Genetic Rearrangement

Clinical cancer research, 2018-07, Vol.24 (14), p.3282-3291

2018

Volltextzugriff (PDF)

Differential regulation of iron homeostasis during human macrophage polarized activation

European journal of immunology, 2010-03, Vol.40 (3), p.824-835

2010

Volltextzugriff (PDF)

Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology

Blood, 2012-01, Vol.119 (2), p.411-421

2012

Volltextzugriff (PDF)

Tumor-conditioned macrophages secrete migration-stimulating factor: a new marker for M2-polarization, influencing tumor cell motility

The Journal of immunology (1950), 2010-07, Vol.185 (1), p.642-652

2010

Volltextzugriff (PDF)

Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2

Blood, 2010-11, Vol.116 (18), p.3677-3680

2010

Volltextzugriff (PDF)

Aurora-A kinase oncogenic signaling mediates TGF-β-induced triple-negative breast cancer plasticity and chemoresistance

Oncogene, 2021-04, Vol.40 (14), p.2509-2523

2021

Volltextzugriff (PDF)

Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy

Proceedings of the National Academy of Sciences - PNAS, 2019-11, Vol.116 (45), p.22730-22736

2019

Volltextzugriff (PDF)

Dual-Targeting Nanoparticles for In Vivo Delivery of Suicide Genes to Chemotherapy-Resistant Ovarian Cancer Cells

Molecular cancer therapeutics, 2017-02, Vol.16 (2), p.323-333

2017

Volltextzugriff (PDF)

In Vitro and In Vivo Activity of IMGN853, an Antibody-Drug Conjugate Targeting Folate Receptor Alpha Linked to DM4, in Biologically Aggressive Endometrial Cancers

Molecular cancer therapeutics, 2018-05, Vol.17 (5), p.1003-1011

2018

Volltextzugriff (PDF)

Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors

Proceedings of the National Academy of Sciences - PNAS, 2019-01, Vol.116 (2), p.619-624

2019

Volltextzugriff (PDF)

Cervical carcinomas that overexpress human trophoblast cell-surface marker (Trop-2) are highly sensitive to the antibody-drug conjugate sacituzumab govitecan

Scientific reports, 2020-01, Vol.10 (1), p.973, Article 973

2020

Volltextzugriff (PDF)

Dual CCNE1/PIK3CA targeting is synergistic in CCNE1-amplified/PIK3CA-mutated uterine serous carcinomas in vitro and in vivo

British journal of cancer, 2016-07, Vol.115 (3), p.303-311

2016

Volltextzugriff (PDF)

Pbx1 restrains myeloid maturation while preserving lymphoid potential in hematopoietic progenitors

Journal of cell science, 2013-07, Vol.126 (Pt 14), p.3181-3191

2013

Volltextzugriff (PDF)

Exome sequencing identifies CTSK mutations in patients originally diagnosed as intermediate osteopetrosis

Bone (New York, N.Y.), 2014-02, Vol.59, p.122-126

2014

Volltextzugriff (PDF)

Epigenetic investigation of variably X chromosome inactivated genes in monozygotic female twins discordant for primary biliary cirrhosis

Epigenetics, 2011-01, Vol.6 (1), p.95-102

2011

Volltextzugriff (PDF)

Efficacy of neratinib in the treatment of HER2/neu-amplified epithelial ovarian carcinoma in vitro and in vivo

Medical oncology (Northwood, London, England), 2017-05, Vol.34 (5), p.91-91, Article 91

2017

Volltextzugriff (PDF)

Type I Collagen Limits VEGFR-2 Signaling by a SHP2 Protein-Tyrosine Phosphatase–Dependent Mechanism 1

Circulation research, 2006-01, Vol.98 (1), p.45-54

2006

Volltextzugriff (PDF)

The chemokine system in cancer biology and therapy

Cytokine & growth factor reviews, 2010-02, Vol.21 (1), p.27-39

2010

Volltextzugriff (PDF)

Novel potential oncogenic and druggable mutations of FGFRs recur in the kinase domain across cancer types

Biochimica et biophysica acta. Molecular basis of disease, 2022-02, Vol.1868 (2), p.166313-166313, Article 166313

2022

Volltextzugriff (PDF)

Embryonic cleavage modeling as a computational approach to sphere packing problem

Journal of theoretical biology, 2007-03, Vol.245 (1), p.77-82

2007

Volltextzugriff (PDF)

A novel variant of VEGFR2 identified by a pan-cancer screening of recurrent somatic mutations in the catalytic domain of tyrosine kinase receptors enhances tumor growth and metastasis

Cancer letters, 2021-01, Vol.496, p.84-92

2021

Volltextzugriff (PDF)

A novel multiple biomarker panel for the early detection of high-grade serous ovarian carcinoma

Gynecologic oncology, 2018-06, Vol.149 (3), p.585-591

2018

Volltextzugriff (PDF)

DHES0815A, a novel antibody-drug conjugate targeting HER2/neu, is highly active against uterine serous carcinomas in vitro and in vivo

Gynecologic oncology, 2021-11, Vol.163 (2), p.334-341

2021

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(40)

Sprache

Englisch
(40)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

Science & Technology
(40)
Humans
(38)
Life Sciences & Biomedicine
(36)
Female
(27)
Animals
(21)
Oncology
(19)
Cell Line, Tumor
(17)
Mice
(17)
Xenograft Model Antitumor Assays
(12)
Middle Aged
(11)
Cancer
(10)
Mutation
(10)
Tumors
(10)
Adult
(9)
Aged
(9)
Obstetrics & Gynecology
(8)
Antineoplastic Agents - Pharmacology
(7)
Chemotherapy
(7)
Mice, Scid
(7)
Biochemistry & Molecular Biology
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Exceptional Response to Pembrolizumab in a Metastatic, Chemotherapy/Radiation-Resistant Ovarian Cancer Patient Harboring a PD-L1-Genetic Rearrangement

Differential regulation of iron homeostasis during human macrophage polarized activation

Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology

Tumor-conditioned macrophages secrete migration-stimulating factor: a new marker for M2-polarization, influencing tumor cell motility

Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2

Aurora-A kinase oncogenic signaling mediates TGF-β-induced triple-negative breast cancer plasticity and chemoresistance

Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy

Dual-Targeting Nanoparticles for In Vivo Delivery of Suicide Genes to Chemotherapy-Resistant Ovarian Cancer Cells

In Vitro and In Vivo Activity of IMGN853, an Antibody-Drug Conjugate Targeting Folate Receptor Alpha Linked to DM4, in Biologically Aggressive Endometrial Cancers

Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors

Cervical carcinomas that overexpress human trophoblast cell-surface marker (Trop-2) are highly sensitive to the antibody-drug conjugate sacituzumab govitecan

Sacituzumab govitecan, an antibody‐drug conjugate targeting trophoblast cell‐surface antigen 2, shows cytotoxic activity against poorly differentiated endometrial adenocarcinomas in vitro and in vivo

Dual CCNE1/PIK3CA targeting is synergistic in CCNE1-amplified/PIK3CA-mutated uterine serous carcinomas in vitro and in vivo

Pbx1 restrains myeloid maturation while preserving lymphoid potential in hematopoietic progenitors

Exome sequencing identifies CTSK mutations in patients originally diagnosed as intermediate osteopetrosis

Epigenetic investigation of variably X chromosome inactivated genes in monozygotic female twins discordant for primary biliary cirrhosis

Efficacy of neratinib in the treatment of HER2/neu-amplified epithelial ovarian carcinoma in vitro and in vivo

Type I Collagen Limits VEGFR-2 Signaling by a SHP2 Protein-Tyrosine Phosphatase–Dependent Mechanism 1

The chemokine system in cancer biology and therapy

Novel potential oncogenic and druggable mutations of FGFRs recur in the kinase domain across cancer types

Embryonic cleavage modeling as a computational approach to sphere packing problem

A novel variant of VEGFR2 identified by a pan-cancer screening of recurrent somatic mutations in the catalytic domain of tyrosine kinase receptors enhances tumor growth and metastasis

A phase 2 evaluation of pembrolizumab for recurrent Lynch‐like versus sporadic endometrial cancers with microsatellite instability

A novel multiple biomarker panel for the early detection of high-grade serous ovarian carcinoma

DHES0815A, a novel antibody-drug conjugate targeting HER2/neu, is highly active against uterine serous carcinomas in vitro and in vivo

Aktive Filter

Suchergebnisse filtern